According to the American Cancer Society, a more sensitive modality, breast magnetic resonance imaging (MRI), is recommended as a supplementary examination to digital mammography2, for women considered at elevated risk of developing breast cancer, including typically women with known pathogenic BReast CAncer susceptibility gene 1/2 (BRCA1/2) mutation(s) and their untested first-degree relatives as well as those with a 20% to 25% lifetime risk or higher as calculated by risk models which account for age of affected relatives. This evidence concerns the gene BRCA1 and breast carcinoma.